Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Lawrence H. Repsher"'
Autor:
Fred Ullrich, Lawrence H. Repsher, David M. Daughton, Robert T. Nowak, Elbert D. Glover, Stephen P. Fortmann, Tajuddin Millatmal, Edward Lichtenstein, Joel D. Killen, Dorothy K. Hatsukami, Kashinath D. Patil, Stephen I. Rennard, Scott A. Heatley
Publikováno v:
Preventive Medicine. 28:113-118
Background.This study was undertaken to evaluate the long-term smoking cessation efficacy of varying doses of transdermal nicotine delivery systems 4 to 5 years post-quit day. Methods.A follow-up study was conducted 48 to 62 months after quit day amo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e11f523f5bd9f61d15e109126fa68a48
https://doi.org/10.1006/pmed.1998.0391
https://doi.org/10.1006/pmed.1998.0391
Autor:
Michael C. Boyars, Mitchell Friedman, A. DeGraff, R. Bone, E. Gershwin, D. W. Cugell, T. Chick, Lawrence H. Repsher, B. M. Cohen, W. Conway, Sheldon R. Braun, R. B. George, Thomas L. Petty, J. A. Kram, David C. Levin, B. Levine, A. S. Buist, Stephen I. Rennard, S. C. Campbell
Publikováno v:
Chest. 105:1411-1419
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68813048327541dfb5a8a039cf09feaf
https://doi.org/10.1378/chest.105.5.1411
https://doi.org/10.1378/chest.105.5.1411
Publikováno v:
Journal of medical toxicology : official journal of the American College of Medical Toxicology. 7(2)
A multidisciplinary team assessed five patients who alleged chronic medically unexplained multiorgan system symptoms described by idiopathic environmental intolerance allegedly triggered by exposure to solvents used in membrane roofing repair work on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8921044e443e8f116ea513d815063a7
https://pubmed.ncbi.nlm.nih.gov/21302017
https://pubmed.ncbi.nlm.nih.gov/21302017
Autor:
Lawrence H. Repsher
Publikováno v:
The Journal of Clinical Pharmacology. 33:856-860
In a double-blind trial, 29 patients were treated for stable, chronic bronchitis with iodinated glycerol (Organidin®, 60 mg four times daily; n = 16) or placebo (n = 13). The study consisted of a 2-week single-blind lead-in period, followed by a 6-w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0d7eadf63a8113da5595bf85420485e
https://doi.org/10.1002/j.1552-4604.1993.tb01963.x
https://doi.org/10.1002/j.1552-4604.1993.tb01963.x
Autor:
Lawrence H. Repsher, Elbert D. Glover, Jessica M. Rath, Philip Tonnesen, Molly T. Laflin, John N. Quiring, Penny N. Glover, Eva Sharma
Publikováno v:
American journal of health behavior. 34(1)
Objective To evaluate the safety and efficacy of sublingual lobeline sulfate for smoking cessation. Methods A multicenter (3 sites), double-blind, parallel, placebo-controlled, phase 3 smoking cessation trial of sublingual formulation of lobeline sul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebfda20afb3213fa9ebf0b0133868cd1
https://pubmed.ncbi.nlm.nih.gov/19663757
https://pubmed.ncbi.nlm.nih.gov/19663757
Autor:
Cindy Reuter, Paul M. Gustman, J. Mark Galbraith, Wayne Silvers, Kathryn R. Laughlin, David C. Levin, Karen McFarland, Thomas L. Petty, Katherine S. Little, David Ostransky, Lawrence H. Repsher, Mary Mueller, Rick Vale, Jerrold A. Kram, Stephen I. Rennard, Debbie Murphy, Richard L. Zuwallack, Grace Hardie
Publikováno v:
The American journal of medicine. 100(1A)
A randomized, double-blind placebo-controlled clinical trial was designed to assess the safety, efficacy, and duration of the bronchodilation resulting from the addition of 500 micrograms of ipratropium bromide (Atrovent; Boehringer Ingelheim, CT) in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf178312b284e48d98d17981717b83a0
https://pubmed.ncbi.nlm.nih.gov/8610716
https://pubmed.ncbi.nlm.nih.gov/8610716
Autor:
Neil Malone, Scott A. Heatley, Linda Ochs, Anthony Biglan, Mark Hansen, Penny N. Glover, Clyde N. Rolf, Jennifer Leitch, Diane Moos, Nancy Trunnell, Elbert D. Glover, Cheryl K. Walker, John S. Hughes, David M. Daughton, Dara Stlllman, Mau Ms, Joel D. Killen, Robert T. Nowak, Lawrence H. Repsher, Donna Causey, Phillip B. Ackerman, William Schones, Mark Knowles, Marguerite Huber, William A. Valliere, Arden G. Christen, Ronald Cheney, Cheryl Casey, Kathleen Hatlelid, William C. Wadland, Dorothy K. Hatsukami, Stephen P. Fortmann, Beiswanger Bb, Della A. Prather, Katherine Voss-Roberts, Austin B. Thompson, Edward Lichtenstein, L. Rasenick Douss, Joni Jensen, Sharon S Allen, Stephen I. Rennard, Bonnie Poole, Laura J. Solomon
Publikováno v:
JAMA. 266:3133
Objective. —To evaluate the efficacy of a new transdermal nicotine system for smoking cessation. Design. —Two 6-week, randomized, double-blind, placebo-controlled, parallel group trials were conducted. Successful abstainers from both trials enrol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b731d3616067940bd9730dea2ad5c21
https://doi.org/10.1001/jama.1991.03470220049025
https://doi.org/10.1001/jama.1991.03470220049025
Autor:
Lawrence H. Repsher
Publikováno v:
Journal of Allergy and Clinical Immunology. 87:257
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f8633c268274616e9eb6d255011610d
https://doi.org/10.1016/0091-6749(91)91755-i
https://doi.org/10.1016/0091-6749(91)91755-i
Publikováno v:
Chest. 86:404-408
Twenty-eight patients with advanced emphysema and/or chronic bronchitis and severe airflow obstruction were randomly assigned to receive either bitolterol or isoproterenol aerosol delivered by a metered dose device which was administered three times
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54a6bf8c88b305c3e108871a5124dacd
https://doi.org/10.1378/chest.86.3.404
https://doi.org/10.1378/chest.86.3.404
Autor:
Paul Chervinsky, Michael J. Neidl, Robert K. Bush, I. Leonard Bernstein, Robert A. Nathan, Bankim D. Bhatt, E Bronsky, Lawrence H. Repsher, Dockhorn Rj, Thomas S. Mingo, Jacob L. Pinnas, John J. Condemi
Publikováno v:
The Journal of allergy and clinical immunology. 79(5)
Bitolterol mesylate, 1.0 mg, or isoproterenol hydrochloride, 1.5 mg, was administered three times daily for 3 months in a double-blind, multicenter study via closed-port, intermittent-flow, compressor-driven nebulizer system (CPIF) to 182 nonsteroid-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d600e56e2a58cc74932f2a8206adfdc
https://pubmed.ncbi.nlm.nih.gov/3571768
https://pubmed.ncbi.nlm.nih.gov/3571768